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Purpose: The objective of this work was to prepare and evaluate fast dissolving tablets of the 
nutraceutical, freeze dried Aloe vera gel. 
Methods: Fast dissolving tablets of the nutraceutical, freeze-dried Aloe vera gel, were prepared by dry 
granulation method. The tablets were evaluated for crushing strength, disintegration time, wetting time, 
friability, drug content and drug release. A 3
2
 full factorial design was applied to investigate the 
combined effect of two formulation variables - amounts of microcrystalline cellulose and mannitol. 
Results: The results of multiple regression analysis revealed that in order to obtain a fast dissolving 
tablet of the Aloe vera gel, an optimum concentration of mannitol and a higher content of 
microcrystalline cellulose should be used. A response surface plot was also provided to graphically 
represent the effect of the independent variables on the disintegration time and wetting time. The validity 
of the generated mathematical model was tested by preparing a check point batch. 
Conclusion: This investigation has demonstrated that satisfactory fast dissolving Aloe vera gel tablets 
can be formulated. It also showed the potential of experimental design in understanding the effect of 
formulation variables on the quality of fast dissolving tablets. 
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INTRODUCTION 
 
The genus, Aloe, belongs to the family, 
Liliaceae, and includes the species Aloe 
barbadensis Miller, commercially known as 
Aloe vera. Aloe vera has been used 
therapeutically for many centuries and is of 
particular interest due to its lengthy historic 
reputation as a curative agent and its  
widespread use in supplementary therapies. 
Aloe gel is the colorless gel contained in the 
inner parts of the fresh leaves
1
. Chemical 
analysis has revealed that this clear gel 
contains amino acids, minerals, vitamins, 
enzymes, proteins, polysaccharides and 
biological stimulators. The Aloe vera gel, 
beginning in the 50's, has gained recognition 
as a base for nutritional drinks and foods
2-4
, as 
a moisturizer, and a healing agent in 
cosmetics
5




Approximately one-third of the population, 
primarily, geriatric and pediatric populations, 
has swallowing difficulties, resulting in poor 
compliance with oral drug therapy
7
. Fast 
dissolving tablets offer the combined 
advantages of performance, convenience, 
rapid onset of action and patient compliance 
and allow administration of an oral solid dose 
form in the absence of water or fluid intake
8
 . 
When placed on the tongue, it disintegrates 
instantaneously, releasing the drug which 





prepared by techniques such as tablet 
molding, spray drying, lyophilization, 




Pharmaceutical formulators often face the 
challenge of finding the right combination of 
formulation variables that will produce a 
product with optimum properties. This study 
was undertaken to formulate a suitable fast 
dissolving nutraceutical tablet of freeze dried 
aloe vera gel (AVG), utilizing factorial design. 
 
MATERIALS AND METHODS 
 
Plant material  
 
A. vera plants were collected (March 2003) 
and authenticated by Dr. C.S. Pandey of 
Medicinal Plant Research and Development 
Centre, Govind Pant University of Agriculture 
and Technology, Pantnagar (Uttarakhand), 
India. A voucher specimen (AV-8) was 




Croscarmellose sodium (CCS), crospovidone 
(CLP) and sodium starch glycolate (SSG) 
were purchased from S.D. Fine Chem., 
Mumbai, India.  Microcrystalline cellulose - 
Avicel PH101 - hereinafter referred to as 
MCC, was procured from FMC Corporation, 
Philadelphia, USA. Mannitol was purchased 
from Merck India Ltd, Mumbai, India. 
Anhydrous lactose, talc, magnesium stearate 
and hydrochloric acid were obtained from 
CDH Chemicals, Delhi, India. Congo red 
reagent and methylene blue were acquired 
from Nice Chemicals Pvt. Ltd, Cochin, India. 
 
Preparation of freeze-dried Aloe vera gel 
(AVG) 
 
The inner mucilaginous parenchymatous 
tissues of leaves of Aloe vera plants were 
separated out with the help of a sterile knife. 
and homogenized in a blender (National 
blender, Matushita Co. Japan)  at 30 rpm. The 
homogenized mass was separated with a G3 
sintered glass filter under vacuum, freeze-
dried using a bench-top freeze-dryer (MC 2L, 





. The ratio of AVG to lyophilized powder 
was 200:1.  
 
Preparation of AVG tablets 
 
A preliminary screening of the disintegrants - 
croscarmellose sodium (CCS), crospovidone 
(CLP), sodium starch glycolate (SSG) and 
microcrystalline cellulose (MCC) - was 
conducted. Mannitol was incorporated as a 
soluble filler to improve palatability, impart a 
cooling sensation and sweet taste upon 
dissolution. Granulation was carried out by the 
dry granulation technique. All the ingredients 
were compressed and slugs of 0.8 g were 
produced at a compression force of 22.0 ± 1.0 
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kN using flat faced tooling 17 mm in diameter 
on a single punch tablet machine (Cadmach 
Machinery Ltd., Ahmedabad, India). 
 
The slugs were then milled and the resulting 
granules sieved through sieve no. 20 USP. 
The granules were further mixed with a 
glidant-lubricant blend containing magnesium 
stearate(1%w/w) and talc (2% w/w) . The 
granules were compressed using a single 
punch tablet machine (Cadmach Machinery 
Ltd., Ahmedabad, India) fitted with 8 mm 
round standard concave punches. The tablet 
thickness was   about 4.56± 0.06mm.  
 




The crushing strength of the tablets (n=5) was 
measured using   a Monsanto hardness tester 




The friability of a sample of 20 tablets was 
measured using a Roche Friabilator 
(Electrolab, India). Twenty preweighed tablets 
were rotated at 25 rpm for 4 min. The tablet 
were then reweighed after removal of fines 





The wetting time of the tablets (n=6) was 
measured using a modified procedure 
described by Gohel et al
12
. Five circular tissue 
papers ( Dexina tissues, Gujarat, India) of 10 
cm diameter were placed in a Petri dish 
(internal diameter 10 cm). Water (10 mL) 
containing methylene blue (10 % w/v), a water 
soluble dye, was added to the Petri dish. A 
tablet was carefully placed in the centre of the 
Petri dish and the time taken for the water to 
reach the upper surface of the tablets was 




This test was performed on 6 tablets. For 
disintegration time, one tablet was placed in 
the centre of the Petri dish (internal diameter 
10 cm ) containing 10 ml of water  and the 





Drug content uniformity 
 
Colorimetric measurement of glucomannan in 
the AVG was used for determining drug 
content uniformity
13
. For the drug content, 10 
tablets were weighed and triturated. A tablet 
triturate, equivalent to 2 mg of AVG, was 
weighed accurately and dissolved in 100 ml of 
distilled water and filtered.  From this solution, 
0.4 ml was transferred to a 10 ml test tube. To 
this, 4 ml of Congo red reagent (0.01 %) was 
added with mild vortexing. The mixture was 
left at room temperature for 20 min and 
absorbance was measured at 540 nm 
wavelength using UV-VIS spectrophotometer 
(SL-196, Elico Ltd). The amount of 
glucomannan was calculated by interpolating 






The in vitro dissolution study was carried out 
in a USP dissolution test apparatus (TDT-OP 
Electrolab, Mumbai India ), type 2 (paddle) 
with a dissolution media of 900 mL of 0.1 M 
hydrochloric acid at 50 rpm (37 ºC + 0.5 ºC). 
Samples (n=6) were withdrawn at the end of 
30 min and the dissolution of drug was 
expressed as percent drug dissolved at the 








randomised factorial design was adopted 
to optimize the variables. In this design, two 
factors were evaluated each at 3 levels and 
experimental trials were performed at all 9 
possible combinations
15
. The amount of 
disintegrant (MCC) and the soluble filler 
(mannitol) were chosen as independent 
variables. The disintegration time and wetting 
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time were selected as the dependent 
variables. The formulation and evaluation of 
factorial batches (F1 to F9) is shown in Table 
2. The following statistical model incorporating 
interactive and polynomial terms was used to 






  ..…(1) 
 
where Y is the dependent variable, b0  is the 
arithmetic mean response of the 9 runs, and 
b1 and b2 are the estimated coefficients for the 
factors X1 and X2 respectively.  
 
The main effects (X1 and   X2) represent the 
average result of changing 1 factor at a time 
from its low to high value. The interaction 
terms (X1 X2) show how the response 
changes when 2 factors are simultaneously 





are included to investigate nonlinearity. The 
multiple regression analysis was performed 




Hardness of the tablets was in the acceptable 
range of 2.56 to 3.55 kg/cm
2
. Friability was 
0.51 to 0.82 %. Drug content and release 
were 100±5% and 82.6-88.4 %, respectively. 
The results of the prelimnary studies (Table 1) 
revealed that the tablets containing 
microcrystalline cellulose (MCC) exhibited 
rapid disintegration and wetting followed by 
tablets containing croscarmellose sodium 
(CCS), crospovidone (CLP), sodium starch 
glycolate (SSG) in that order.   
Factorial design 
The amount of disintegrant (MCC, X1) and the 
soluble filler (mannitol, X2) were chosen as 
independent variables in a 3
2
 full factorial 
design. The disintegration time and wetting 
time were selected as the dependent 
variables. The data (Table 2) clearly indicates 
that disintegration time and wetting time are 
strongly dependent on the selected 
independent variables. The fitted equations 
(full and reduced) relating the responses, 
disintegration time and wetting time, to the 




Preliminary trials  
 
In order to select the best disintegrant, four 
disintegrants were studied in preliminary trials. 
The efficiency of disintegrants can be affected 
in varying magnitudes by the presence of a 
soluble filler in the tablet formulations
16
. This 
is expected due to the fact that the quantity of 
water penetrating into the tablet bed is limited. 
The soluble filler (mannitol) has good aqueous 
solubility, negative heat of solution and good 
wetting properties
17
. Mannitol will consume 
water partially, leaving only a part of the total 
water to penetrate into the tablet for the 
development of force necessary for 
disintegration. The results of the preliminary 
studies (Table 1) revealed that the tablets 
containing microcrystalline cellulose (MCC) 
exhibited rapid disintegration and wetting. 
MCC has good wicking and absorbing 
capacities
18
. Tablets of MCC disintegrated 
rapidly due to the rapid passage of water into 
the tablets resulting in the instantaneous 
rupture of the hydrogen bonds
19
. The delayed 
disintegration and wetting time of the tablets 
formulated using other disintegrants could be 
attributed to their slow water uptake and high 
gelling tendency. Based on the results of the 
preliminary study, MCC was selected as the 
disintegrant for further studies. The optimum 
concentration of MCC may be less than 12 %.  
 
Factorial design   
 
The polynomial equations can be used to 
draw conclusions after considering the 
magnitude of coefficient and the mathematical 
sign it carries (i.e., positive or negative). Table 
4 shows the results of the analysis of variance 
(ANOVA), which was performed to identify 
insignificant factors. The high values of 
correlation coefficient for disintegration time 
and wetting time (Table 4) indicate a good fit. 
The equations may be used to obtain 
estimates of the response as a small error of 
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Table 1:  Tablet formulation and evaluation of preliminary trials*  
 
Ingredient                                                                                Batch code 
  A1 A2 A3 A4 
Freeze dried aloe vera gel (mg) 150 150 150 150 
Microcrystalline cellulose (mg)  25 - - - 
Croscarmellose sodium (mg)  - 25 - - 
Sodium starch glycolate (mg)  - - 25 - 
Crospovidone  (mg) - - - 25 
Mannitol (mg)  150 150 150 150 
Anhydrous lactose q .s  to---(mg)  400 400 400 400 
Disintegration time (sec) 36.5 41.8 49.2 45.6 
Wetting  time (sec) 32.5 36.8 43.6 39.4 
Hardness (Kg/cm
2
) 3.55 3.24 2.56 2.96 
Friability (% loss) 0.56 0.76 0.82 0.83 
Drug content(%) 














 Full factorial design layout* 
 




     X1 (mg)            X2 (mg)             ± SD (sec)                         ±SD(sec) 
F1 -1 +1 36.75 ± 2.25 34.20 ± 0.75 
F2 0 +1 36.33 ± 1.85 32.40 ± 1.08 
F3 +1 +1 35.45 ± 3.32 32.66 ± 1.87 
F4 -1 0 34.55 ± 3.12 30.54 ± 0.63 
F5 0 0 34.00 ± 1.33 29.89 ± 1.23 
F6 +1 0 33.24 ± 1.53 29.62 ± 0.89 
F7 -1 -1 34.23 ± 2.45 31.66 ± 0.66 
F8 0 -1 34.40 ± 4.23 30.90 ± 0.76 
F9 +1 -1 34.14 ± 1.88 30.00 ± 1.23 
Check point    +0.8        -0.2                         33.6                                  29.2 
Actual values  
Coded values                                X1                                                                                       X2 
-1 10 100 
0 20 150 
1 30 200 
 
*All batches contained   150 mg AVG, 2%w/w talc, 1%w/w magnesium stearate. 
X1 indicates amount of MCC(mg); X2 is amount of mannitol (mg); SD = standard deviation. 
 
 
Full and reduced models 
 
The significance level of coefficients, b12 and 
b11, were found to be more than 0.05, hence 
they were omitted from the full model to 
generate the reduced model. The results of 
statistical analysis are shown in Table 3. The 
coefficients, b1, b2 and b22, were found to be 
significant at P < 0.05; hence they were 
retained in the reduced model. The reduced 
model was tested in portions to determine 
whether the coefficient b12 and b11 contributed 
significant information for the prediction of 
both disintegration time and wetting time. The 
results for the test of the model in portions are 
shown in Table 4. F-Statistics of the results of  
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Table 3: Summary of results of regression analysis* 
 
For disintegration time 
Response (disintegration 
time) 
b0 b1 b2 b12 b11 b22 
FM 34.052 -0.450 0.960 -0.183 -0.303 1.287 
RM 33.930 -0.450 0.960 - - 1.287 
For wetting time 
Response (Wetting time) b0 b1 b2 b12 b11 b22 
FM 29.761 -0.687 1.117 0.383 0.0300 1.953 
RM 30.017 -0.687 1.117 - - 1.953 
 
*FM indicates full model; and RM, reduced model 
 
Table 4: Calculations for testing the model in portions* 
 
For disintegration time  
 DF SS MS F R
2
 
Regression      
FM 5 10.489 2.098 47.574 0.988 
Fcalc = 4.920 
Ftable = 9.55 
DF = (2,3) 
RM 3 10.056 3.352 29.635 0.947  
Error       
FM 3 0.132 0.0441    
RM 5 0.566 0.113    
For wetting time 
 DF SS MS F R
2
 
Regression      
FM 5 18.239 3.648 18.397 0.968 
Fcalc = 0.198 
Ftable = 9.55 
DF = (2,3) 
RM 3 17.942 5.981 33.511 0.953  
Error       
FM 3 0.595 0.198    
RM 5 0.892 0.178    
 
             *DF indicates: degrees of freedom; SS, sum of squares; MS, mean of squares; F, Fischer's ratio;  
R
2
, regression coefficient; FM, full model; and RM, reduced model.  
 
ANOVA of full and reduced model confirmed 
omission of non-significant terms of equation 
1. Since the calculated value (4.92 and 0.198) 
is less than the tabulated value (9.55,α=0.05, 
df 2,3), it may be concluded that the 
interaction terms b12 and the polynomial term 
b11 do not contribute significantly to the 
prediction of both disintegration time and  
wetting time and, therefore, can be omitted 
from the full model. The results of multiple 
linear regression analysis (reduced model) 
show that for both disintegration time and 
wetting time, the amount of MCC (X1) had a 
negative effect while the concentration of 
mannitol (X2) had a positive effect. It means 
that as the amount of MCC is increased, both 
the disintegration time and wetting time 
decreases, while as the amount of mannitol is 
increased both the disintegration time and 
wetting time would increase. Therefore, a high 
level of MCC and low level of mannitol should 
be selected for the rapid disintegration of the 
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tablets. The relationship between the 
dependent and independent variables was 
further elucidated using surface response 
plots. The data of the response surface plot 
(Figures 1 and 2)) demonstrate that both X1 
and X2 affect the disintegration and wetting 
times. Based on the foregoing, discussion 
batch F6 (disintegration time: 33.24 sec and 
wetting time: 29.62 sec) was selected as a 
promising batch. A checkpoint batch was 
prepared at X1 = + 0.8 level and X2= -0.2 level. 
The values of disintegration and wetting times 
expected from the reduced model for this 
batch are 33.78 and 29.32 sec, respectively. 
Table 2 indicates the results were as 
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The results of a 3
2
 full factorial design 
revealed that the amount of microcrystalline 
cellulose and mannitol significantly affect the 
dependent variables - disintegration and 
wetting times. The present study has revealed 
the feasibility of optimization procedure in 
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